Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2026 for Definium Therapeutics, Inc., €350k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Daniel Rollings Karlin: trading record in brief
All filings by Daniel Rollings Karlin on record concern Definium Therapeutics, Inc. The record holds 2 filings, for trades running from 25 June 2026 to 25 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 25 September 2026, reports a transaction of €350k in Definium Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel Rollings Karlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,853 shares@ US$36.73CommonSEC144:0001950047-26-009814
10,035 shares@ US$42.13100.0% of flowCommonSEC144:0001950047-26-006489
2 of 2 declarations
